Published in J Exp Anal Behav on January 01, 1972
Compounding of discriminative stimuli that maintain responding on separate response levers. J Exp Anal Behav (1973) 1.15
The development of stimulus control with and without a lighted key. J Exp Anal Behav (1972) 1.14
A quantitative analysis of the responding maintained by interval schedules of reinforcement. J Exp Anal Behav (1968) 32.57
Attention in the pigeon. J Exp Anal Behav (1961) 10.05
Auditory thresholds in the pigeon. Am J Psychol (1953) 2.07
Attention shifts in a maintained discrimination. Science (1969) 1.74
Large-scale reductions in speeding and accidents in Canada and Israel: a behavioral ecological perspective. J Appl Behav Anal (1985) 2.93
GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92
An analysis of some variables influencing the effectiveness of reprimands. J Appl Behav Anal (1982) 2.76
Social valdiation: the evolution of standards of competency for target behaviors. J Appl Behav Anal (1979) 2.19
Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology (N Y) (1991) 1.88
A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry (1991) 1.83
Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol (1998) 1.75
Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol (1991) 1.69
Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology (N Y) (1991) 1.65
Fluorescence in situ hybridization shows spatial distribution of as yet uncultured treponemes in biopsies from digital dermatitis lesions. Microbiology (1998) 1.55
Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry (1979) 1.49
Refolding and association of oligomeric proteins. Methods Enzymol (1986) 1.47
The use of feedback signs to increase observed daytime seat belt use in two cities in North Carolina. Accid Anal Prev (1996) 1.46
Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol (1999) 1.45
The ultrastructure of chronic radiation damage in rat skin. Surg Gynecol Obstet (1981) 1.43
Operant extinction in the treatment of severe maladaptive behavior: adapting research to practice. Behav Modif (1994) 1.41
Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer. Cancer Invest (2000) 1.39
A modest proposal to (maybe) avoid cervical disc disease. Plast Reconstr Surg (1998) 1.39
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
Fournier's syndrome: synergistic gangrene of the scrotum. Am J Surg (1975) 1.35
Reconstitution of a heat shock effect in vitro: influence of GroE on the thermal aggregation of alpha-glucosidase from yeast. Biochemistry (1991) 1.34
Tumor induction by human adenovirus type 12 in hamsters: loss of the viral genome from adenovirus type 12-induced tumor cells is compatible with tumor formation. EMBO J (1982) 1.31
Analysis of the reconstitution of oligomeric enzymes by cross-linking with glutaraldehyde: kinetics of reassociation of lactic dehydrogenase. Biochemistry (1981) 1.28
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry (2000) 1.23
Using time delay to promote spontaneous speech in an autistic child. J Appl Behav Anal (1991) 1.22
Comparing treatment techniques: a cautionary note. J Appl Behav Anal (1987) 1.22
The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem (2001) 1.22
Movement suppression time-out for undesirable behavior in psychotic and severely developmentally delayed children. J Appl Behav Anal (1985) 1.21
The role of a physical fitness program in the treatment of alcoholism. J Stud Alcohol (1982) 1.20
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology (2007) 1.20
Reversible high-pressure dissociation of lactic dehydrogenase from pig muscle. Biochemistry (1980) 1.19
The refined structures of a stabilized mutant and of wild-type pyruvate oxidase from Lactobacillus plantarum. J Mol Biol (1994) 1.15
The development of stimulus control with and without a lighted key. J Exp Anal Behav (1972) 1.14
Silicon identification in prosthesis-associated fibrous capsules. Science (1978) 1.13
Folding of a synthetic parallel beta-roll protein. FEBS Lett (2000) 1.13
The effects of nighttime seat belt enforcement on seat belt use by tavern patrons: a preliminary analysis. J Appl Behav Anal (1988) 1.12
A fusion protein designed for noncovalent immobilization: stability, enzymatic activity, and use in an enzyme reactor. Nat Biotechnol (1996) 1.12
Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology (1979) 1.10
The reconstitution of denatured phosphoglycerate mutase. J Biol Chem (1983) 1.10
Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure. J Mol Biol (1995) 1.08
Prolyl isomerases catalyze antibody folding in vitro. Protein Sci (1993) 1.08
[Allergies to animal hair in diseases of the upper respiratory tract (author's transl)]. Dtsch Med Wochenschr (1975) 1.08
The reticuloendothelial system in scrapie pathogenesis. J Gen Virol (1984) 1.06
Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. Biochemistry (1994) 1.06
Properties of the infectious bursal agent of chicken (IBA). Med Microbiol Immunol (1972) 1.06
Quaternary structure, subunit activity, and in vitro association of porcine mitochondrial malic dehydrogenase. Biochemistry (1979) 1.05
A cartridge for running long variable-interval tapes. J Exp Anal Behav (1970) 1.05
Alternatively folded states of an immunoglobulin. Biochemistry (1991) 1.05
Auditory stimulus control in pigeons: Jenkins and Harrison (1960) revisited. J Exp Anal Behav (1977) 1.05
Mechanism of refolding and reactivation of lactic dehydrogenase from pig heart after dissociation in various solvent media. Biochemistry (1977) 1.05
Healing in the irradiated wound. Clin Plast Surg (1990) 1.05
Stability and reconstitution of pyruvate oxidase from Lactobacillus plantarum: dissection of the stabilizing effects of coenzyme binding and subunit interaction. Protein Sci (1992) 1.05
Fibroblast senescence in pressure ulcers. Wound Repair Regen (1999) 1.04
Folding and association of triose phosphate isomerase from rabbit muscle. Z Naturforsch C (1981) 1.04
Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material. Biomaterials (1994) 1.03
Folding and association of beta-Galactosidase. J Mol Biol (1998) 1.03
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J Mol Biol (1996) 1.02
Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 2. Reactivation of irreversibly denatured aggregates. Biochemistry (1979) 1.00
Aerobic fitness level and reactivity to psychosocial stress: physiological, biochemical, and subjective measures. Psychosom Med (1983) 1.00
The incidence and characteristics of violent men in substance abuse treatment. Addict Behav (1999) 0.99
Skin ulcers due to adriamycin. Cancer (1976) 0.99
Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng (1992) 0.98
Biliary cancer among Southwestern American Indians. Ariz Med (1970) 0.98
Proteolytic dimers of porcine muscle lactate dehydrogenase: characterization, folding, and reconstitution of the truncated and nicked polypeptide chain. Biochemistry (1987) 0.97
Kinetics of reassociation and reactivation of pig-muscle lactic dehydrogenase after acid dissociation. Eur J Biochem (1976) 0.97
Pressure (decubitus) ulcer: variation in histopathology--a light and electron microscope study. Hum Pathol (1995) 0.96
Usefulness of data on albumin and prealbumin concentrations in determining effectiveness of nutritional support. Clin Chem (1989) 0.96
Dissociation and in vitro reconstitution of bovine liver uridine diphosphoglucose dehydrogenase. The paired subunit nature of the enzyme. Biochemistry (1986) 0.96
Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur J Biochem (1993) 0.96
Wide spread scars, hypertrophic scars, and keloids. Clin Plast Surg (1987) 0.95
Improved refolding of an immobilized fusion protein. Nat Biotechnol (1996) 0.95
Stabilization of creatinase from Pseudomonas putida by random mutagenesis. Protein Sci (1993) 0.94
Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor. J Mol Biol (2001) 0.94
Mechanism of assembly of recombinant murine polyomavirus-like particles. J Virol (2000) 0.94
Neuronal ceroidosis (ceroid-lipofuscinosis) in a Blue Heeler dog. Acta Neuropathol (1986) 0.94
The ultrastructure and etiology of chronic radiotherapy damage in human skin. Ann Plast Surg (1982) 0.94
Location of the force of wound contraction. Surg Gynecol Obstet (1979) 0.93
Comparative growth dynamics and actin concentration between cultured human myofibroblasts from granulating wounds and dermal fibroblasts from normal skin. Lab Invest (1989) 0.93
Violent substance abusers in domestic violence treatment. Violence Vict (1999) 0.92
Histopathological Examinations of nasal polyps of different etiology. Arch Otorhinolaryngol (1980) 0.92
The life cycle of the myofibroblast. Surg Gynecol Obstet (1977) 0.92
The myofibroblast. Surg Gynecol Obstet (1978) 0.92
Cosecretion of chaperones and low-molecular-size medium additives increases the yield of recombinant disulfide-bridged proteins. Appl Environ Microbiol (2001) 0.92
The HU protein from Thermotoga maritima: recombinant expression, purification and physicochemical characterization of an extremely hyperthermophilic DNA-binding protein. J Mol Biol (1999) 0.92
Alcoholics also dependent on cocaine in treatment: do they differ from "pure" alcoholics? Addict Behav (1994) 0.91
Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur J Immunol (1992) 0.91
Inhibition of myofibroblasts by skin grafts. Plast Reconstr Surg (1979) 0.91
The effects of a specific prompting sign on speed reduction. Accid Anal Prev (1987) 0.91
Cancer of the gallbladder in an 11-yr-old Navajo girl. J Pediatr Surg (1972) 0.91
Limited proteolysis of gamma II-crystallin from calf eye lens. Physicochemical studies on the N-terminal domain and the intact two-domain protein. Eur J Biochem (1990) 0.91
Alcohol and cocaine abusers 6 months after traditional treatment: do they fare as well as problem drinkers? J Subst Abuse Treat (1994) 0.89
Venlafaxine for treatment-resistant unipolar depression. J Clin Psychopharmacol (1994) 0.89
Rate-determining folding and association reactions on the reconstitution pathway of porcine skeletal muscle lactic dehydrogenase after denaturation by guanidine hydrochloride. Biochemistry (1982) 0.89
Kinetics of reconstitution of porcein muscle lactic dehydrogenase after reversible high pressure dissociation. Biophys Chem (1980) 0.89
Effect of zinc(II) on the refolding and reactivation of liver alcohol dehydrogenase. Eur J Biochem (1978) 0.89
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design. Structure (1996) 0.89
Summation of punishment suppression. J Exp Anal Behav (1971) 0.88
Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA. J Biotechnol (2001) 0.88